EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

RAB13 promotes diffuse large B-cell lymphoma progression and reduces lenalidomide sensitivity via PIK3CA-associated PI3K–AKT–mTOR signaling

Bin Tang, Wen Yang, Dan Xu, Yun Luo, Wenxiu Yang

Annals of Hematology · 21.08.2026 · 105 (12)

DOI: 10.1007/s00277-026-07229-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, online erschienen am 21.08.2026. Verfasst von Bin Tang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Guizhou Medical University, The Affiliated Hospital of Guizhou Medical University, 28 Beijing Road, Guiyang, 550001, Guizhou…. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, TOR Serine-Threonine Kinases, Proto-Oncogene Proteins c-akt, Class I Phosphatidylinositol 3-Kinases. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Research and Development Program of the Science and Technology Department of Guizhou Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Large B-Cell, DiffuseTOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktClass I Phosphatidylinositol 3-Kinasesrab GTP-Binding ProteinsLenalidomideHumansAnimalsSignal TransductionMiceFemaleCell Line, TumorMalePhosphatidylinositol 3-KinasesXenograft Model Antitumor AssaysDisease ProgressionDrug Resistance, Neoplasm

Stichwörter der Autor:innen

Activated B-cell-like diffuse large B-cell lymphoma (ABC-DLBCL)Lenalidomide sensitivityPI3K–AKT–mTOR signalingPIK3CARAB13

Substanzen

TOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktClass I Phosphatidylinositol 3-KinasesPIK3CA protein, humanrab GTP-Binding ProteinsMTOR protein, humanLenalidomidePhosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • Department of Pathology, Guizhou Medical University, The Affiliated Hospital of Guizhou Medical University, 28 Beijing Road, Guiyang, 550001, Guizhou, P. R. China.
  • Department of Pathology, Guizhou Medical University, The Affiliated Hospital of Guizhou Medical University, 28 Beijing Road, Guiyang, 550001, Guizhou, P. R. China. yangwenxiu4312@gmc.edu.cn.
  • School of Clinical Medicine, Guizhou Medical University, Guiyang, 550001, Guizhou, P. R. China. yangwenxiu4312@gmc.edu.cn.

Förderung

  • Key Research and Development Program of the Science and Technology Department of Guizhou Province

Zitieren

APA

Tang, B., Yang, W., Xu, D., Luo, Y., & Yang, W. (2026). RAB13 promotes diffuse large B-cell lymphoma progression and reduces lenalidomide sensitivity via PIK3CA-associated PI3K–AKT–mTOR signaling. Annals of Hematology, 105(12). https://doi.org/10.1007/s00277-026-07229-0

Vancouver

Tang B, Yang W, Xu D, Luo Y, Yang W. RAB13 promotes diffuse large B-cell lymphoma progression and reduces lenalidomide sensitivity via PIK3CA-associated PI3K–AKT–mTOR signaling. Annals of Hematology. 2026;105(12). doi:10.1007/s00277-026-07229-0

BibTeX
@article{Tang2026,
  author = {Tang, Bin and Yang, Wen and Xu, Dan and Luo, Yun and Yang, Wenxiu},
  title = {RAB13 promotes diffuse large B-cell lymphoma progression and reduces lenalidomide sensitivity via PIK3CA-associated PI3K–AKT–mTOR signaling},
  journal = {Annals of Hematology},
  year = {2026},
  volume = {105},
  number = {12},
  doi = {10.1007/s00277-026-07229-0}
}
Kostenlos starten →